The global surgical drains market was valued at $2,054.0 million in 2020, and is projected to reach $3,075.2 million by 2030, registering a CAGR of 4.1% from 2021 to 2030. Furthermore, based on volume the global surgical drains market was estimated at 75.5 million pieces in 2020, and is projected to reach 95.5 million pieces by 2030, registering a CAGR of 2.0% from 2021 to 2030.
Surgical drains are implants that allow removal of fluid and/or gas from a wound or body cavity. These drains are tubes placed near surgical incisions in the post-operative patients to remove pus, blood, or other fluid, preventing it from accumulating in the body. They are active drains that maintain a negative pressure gradient. Drains can help in the healing process by removing inflammatory mediators, bacteria, foreign material, and necrotic tissue. They can relieve pressure that can impair perfusion or cause pain, thereby decreasing morbidity and inflammation, they enable monitoring for potential complications by allowing easy sampling of fluid during healing; and can be used to address complications associated with dead space after a pathology report has determined that neoplasia resection is complete and margins are adequate. The type of drainage system inserted is based on the needs of patients, type of surgery, type of wound, amount of drainage expected, and surgeon preferences. Surgical drains are composed of a variety of substances, such as latex or plastic and are used in a wide variety of different types of surgeries such as breast surgery (to prevent collection of blood and lymph), orthopedic procedures (associated with greater blood loss), and chest surgery (the associated risks of raised intrathoracic pressure and tamponade).
Impact of COVID-19 pandemic is expected to remain negative for the surgical drains market, owing to decline in surgical producers as many small hospitals or clinics were shut down and remaining hospitals were being converted to containment facilities and treatment wards for COVID-19 patients. Furthermore, guidelines issued by governments to provide surgical services to patients who require urgent attention and postpone the surgeries if not urgent led to decline in demand for surgical drains products that are used after-surgery to drain out blood, pus, or fluids from surgical site.
For instance, according to research conducted by the CovidSurg Collaborative, a research network in 2020, it was found that surgical procedures were canceled most frequently, with 6.3 million orthopedic surgeries canceled worldwide over a 12-week period, which negatively impacted growth of the surgical drains market. In addition, according to a study conducted on Chile and based on articles published in the National Library of Medicine, a total of 1,330,477 hospital discharges were identified in 2020, of which 99,333 were orthopedic surgical procedures. Compared to 2019, the overall reduction in the total hospital discharges was 19%, and the orthopedic surgical work reduced by 22.8%. All surgical procedures were adversely affected, with fracture/trauma surgeries being the least affected. The maximum adverse impact was witnessed in knee arthroplasty (-64%), followed by hip arthroplasty (-41%) and knee ligament reconstruction (-44%).
The market is expected to witness a moderate growth during the forecast period, owing to rise in adoption of advanced surgical drains along with various technological advancements and their increasing applications in the healthcare sector. Furthermore, increase in geriatric population along with various technological advancements in the market to meet the unmet needs of patients provides significant opportunities for existing players and new entrants.
However, rise in adoption and prevalence of minimally invasive surgeries among people is expected to obstruct growth of the global surgical market. In addition, complications regarding the use and rise in risk of infections are expected to hamper the market growth.
The global surgical drains market is segmented on the basis of products, type, application, end user, and region. On the basis of product, the market is divided into open surgical drainage systems and closed surgical drainage market. By type, it is classified into active drains and passive drains. The application segment includes general surgery, cardiac & thoracic surgery, orthopedic surgery, obstetric/gynecological surgery, and other surgeries. Depending on end user, it is fragmented into hospitals and ambulatory surgical centers & clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the key players operating in the global surgical drains market include ConvaTec Group Plc, Cardinal Health Inc., Medtronic Plc, Johnson & Johnsons (Ethicon Inc.), Medline Industries Inc., B Braun, Redax S.P.A, Romsons Group Private Ltd, Becton, Dickinson and Company(C.R.BARD, INC.), and Stryker Corporation.
Surgical drains are implants that allow removal of fluid and/or gas from a wound or body cavity. These drains are tubes placed near surgical incisions in the post-operative patients to remove pus, blood, or other fluid, preventing it from accumulating in the body. They are active drains that maintain a negative pressure gradient. Drains can help in the healing process by removing inflammatory mediators, bacteria, foreign material, and necrotic tissue. They can relieve pressure that can impair perfusion or cause pain, thereby decreasing morbidity and inflammation, they enable monitoring for potential complications by allowing easy sampling of fluid during healing; and can be used to address complications associated with dead space after a pathology report has determined that neoplasia resection is complete and margins are adequate. The type of drainage system inserted is based on the needs of patients, type of surgery, type of wound, amount of drainage expected, and surgeon preferences. Surgical drains are composed of a variety of substances, such as latex or plastic and are used in a wide variety of different types of surgeries such as breast surgery (to prevent collection of blood and lymph), orthopedic procedures (associated with greater blood loss), and chest surgery (the associated risks of raised intrathoracic pressure and tamponade).
Impact of COVID-19 pandemic is expected to remain negative for the surgical drains market, owing to decline in surgical producers as many small hospitals or clinics were shut down and remaining hospitals were being converted to containment facilities and treatment wards for COVID-19 patients. Furthermore, guidelines issued by governments to provide surgical services to patients who require urgent attention and postpone the surgeries if not urgent led to decline in demand for surgical drains products that are used after-surgery to drain out blood, pus, or fluids from surgical site.
For instance, according to research conducted by the CovidSurg Collaborative, a research network in 2020, it was found that surgical procedures were canceled most frequently, with 6.3 million orthopedic surgeries canceled worldwide over a 12-week period, which negatively impacted growth of the surgical drains market. In addition, according to a study conducted on Chile and based on articles published in the National Library of Medicine, a total of 1,330,477 hospital discharges were identified in 2020, of which 99,333 were orthopedic surgical procedures. Compared to 2019, the overall reduction in the total hospital discharges was 19%, and the orthopedic surgical work reduced by 22.8%. All surgical procedures were adversely affected, with fracture/trauma surgeries being the least affected. The maximum adverse impact was witnessed in knee arthroplasty (-64%), followed by hip arthroplasty (-41%) and knee ligament reconstruction (-44%).
The market is expected to witness a moderate growth during the forecast period, owing to rise in adoption of advanced surgical drains along with various technological advancements and their increasing applications in the healthcare sector. Furthermore, increase in geriatric population along with various technological advancements in the market to meet the unmet needs of patients provides significant opportunities for existing players and new entrants.
However, rise in adoption and prevalence of minimally invasive surgeries among people is expected to obstruct growth of the global surgical market. In addition, complications regarding the use and rise in risk of infections are expected to hamper the market growth.
The global surgical drains market is segmented on the basis of products, type, application, end user, and region. On the basis of product, the market is divided into open surgical drainage systems and closed surgical drainage market. By type, it is classified into active drains and passive drains. The application segment includes general surgery, cardiac & thoracic surgery, orthopedic surgery, obstetric/gynecological surgery, and other surgeries. Depending on end user, it is fragmented into hospitals and ambulatory surgical centers & clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the key players operating in the global surgical drains market include ConvaTec Group Plc, Cardinal Health Inc., Medtronic Plc, Johnson & Johnsons (Ethicon Inc.), Medline Industries Inc., B Braun, Redax S.P.A, Romsons Group Private Ltd, Becton, Dickinson and Company(C.R.BARD, INC.), and Stryker Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical drains market analysis from 2020 to 2030 to identify the prevailing surgical drains market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the surgical drains market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Surgical drains industry player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global surgical drains market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Open surgical drainage system
- Closed surgical drainage system
By Application
- General Surgery
- Cardiac Thoracic Surgery
- Orthopedic Surgery
- Obstetric/Gynecological Surgery
- Other Surgeries
By Type
- Active Drains
- Passive Drains
By End User
- Hospitals
- Ambulatory surgery centers (ASCs) clinics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- BRAUN MELSUNGEN AG
- BECTON DICKINSON & COMPANY (C.R.BARD, INC.)
- CARDINAL HEALTH INC.
- CONVATEC GROUP PLC
- JOHNSON & JOHNSON (ETHICON INC.)
- MEDLINE INDUSTRIES INC.
- MEDTRONIC PLC.
- REDAX S.P.A
- ROMSONS GROUP PRIVATE. LTD
- STRYKER CORPORATION
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: SURGICAL DRAINS MARKET, BY PRODUCT
CHAPTER 5: SURGICAL DRAINS MARKET, BY APPLICATION
CHAPTER 6: SURGICAL DRAINS MARKET, BY TYPE
CHAPTER 7: SURGICAL DRAINS MARKET, BY END USER
CHAPTER 8: SURGICAL DRAINS MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Surgical Drains Market,' the surgical drains market size was valued at $2.1 billion in 2020, and is estimated to reach $3.1 billion by 2030, growing at a CAGR of 4.1% from 2021 to 2030.A surgical drainage device is an equipment that removes excess fluid or air or infected blood from the operation site or wound so that the risk of formation of hematoma is reduced and wound healing process is accelerated to ensure speedy recovery of the patient. Surgical drainage devices consist of soft pliable tubes, which are used to remove the pus, blood, and fluid from the wound, preventing it from accumulating in the body. There are various types of drain such as Jackson Pratt drain, Blake drain, Penrose drain, Chest tube, and Redivac drain.
The overall IMPACT OF COVID-19 remains negative for surgical drains market due to nationwide lockdown have been adopted by various countries across the world to stop the transmission of disease which led to decline in number surgeries. As during the surgical procedures patients are always in close contact with surgeons, which increases the risk of disease transmission. In addition, guidelines issued by government in COVID-19 to provide surgical services to patients who require urgent attention and postpone the surgeries if not urgent, which lead to decline in the demand for surgical drains products which are used post-surgery. For instance, report from Hong Kong in 2020, based on experience with SARS, had showed that the risk of infection is 5% for physicians, 4% for nurses, and 8% for healthcare assistants. It emphasized the importance of practicing strict isolation, infection control measures, and adherence to use of personal protective equipment (PPE).
Furthermore, the surgeons are prioritizing only urgent surgeries and enforcing reasonable delays for non-urgent surgeries after a case-by-case evaluation as per World Health Organization (WHO) guideline during lockdown, till the market opens completely. Thus, COVID-19 had influenced surgical drain market in negative way which can restrain the market growth in upcoming years.
Increase in incidences and prevalence of chronic diseases, increasing geriatric population, rise in number of surgeries, and increase in incidences of target diseases, globally are major drivers of the market. Furthermore, increased tobacco and alcohol consumption, rise in number of cancer-related surgeries, are factors driving the market globally. Moreover, the medical technological companies are focused on undertaking key strategies such as product launch, product approval and among others to strengthen the product portfolio, thereby enhancing opportunities in fast growing clinical areas in various regions.
For instance, Altitude Dry Suction Chest Drainage Unit is a device developed by Medtronic to remove accumulated fluid using wall suction in cardiothoracic surgeries, which reduces the clot build up and adjacent tissue trauma.
However, factors such as increase in number of minimally invasive processes, complications associated with usage of the systems and increase in chances for infection are expected to hamper the growth of the market up to some extent over the forecast period.
The global surgical drains market share is segmented based on products, type, application, end user, and region. On the basis of product, the market is divided into open surgical drainage systems and closed surgical drainage market. By type, it is classified into active drains and passive drains. The application segment includes general surgery, cardiac & thoracic surgery, orthopedic surgery, obstetric/gynecological surgery, and other surgeries. Depending on end user, the market is fragmented into hospitals, and ambulatory surgical centers & clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By product type, the surgical drains market segmented into closed surgical drainage and open surgical drainage. The surgical drains market for closed surgical drainage system was the highest revenue contributor to the market, with $1,541.3 million in 2020, and is estimated to reach $2,400.0 million by 2030, with a CAGR of 4.5%. Furthermore, based on volume the surgical drains market for closed surgical drainage system was the highest revenue contributor to the market, with 57.4 million pieces in 2020, and is estimated to reach $74.3 million pieces by 2030, with a CAGR of 2.3%. Owing to their accessibility, ability to be used in areas that are difficult to bandage, easy collection of fluid for cytology or chemical analysis with less possibility of environmental contamination of the fluid, ability to minimize the build-up of air along with characterization of fluid, and rise in number of surgical procedures are expected to drive the surgical drains market trends.
By type, the global surgical drains market is classified into processing passive drains and active drains. the surgical drains market for active drains was the highest revenue contributor to the market, with $1,578.6 million in 2020, and is estimated to reach $2,320.4 million by 2030, with a CAGR of 3.9%. Furthermore, based on volume the surgical drains market for active drains was the highest revenue contributor to the market, with 55.1 million pieces in 2020, and is estimated to reach $68.4 million pieces by 2030, with a CAGR of 1.8 %. Owing to increase in use of active drains due to lower risk of retrograde infections, accurate measurement of drainage. and skin protection from irritating discharge.
By application, the global surgical drains market is classified into general surgery, cardiac & thoracic surgery, Orthopedic Surgery, Obstetric/Gynecological Surgery, and other surgeries. the surgical drains market for general surgery was the highest revenue contributor to the market, with $613.7 million in 2020, and is estimated to reach $909.7 million by 2030, with a CAGR of 4.0%. Furthermore, based on volume the surgical drains market growth for general surgery was the highest revenue contributor to the market, with 22.7 million pieces in 2020, and is estimated to reach $28.4 million pieces by 2030, with a CAGR of 1.9 %. Owing to increase prevalence of musculoskeletal diseases, such as rheumatoid arthritis, lupus erythematous, and osteoporosis and increasing number of orthopedic procedures, such as hip replacement and knee replacement globally.
On the basis of end user, the global surgical drains industry is divided into hospitals and ambulatory surgical clinics & centers. the surgical drains market for hospitals was the highest revenue contributor to the market, with $1,719.7 million in 2020, and is estimated to reach $2,550.0 million by 2030, with a CAGR of 4.0%. Furthermore, based on volume the surgical drains market for hospitals was the highest revenue contributor to the market, with 47.8 million pieces in 2020, and is estimated to reach $59.7 million pieces by 2030, with a CAGR of 1.9%. Due to a large number of surgeries conducted. The global increase in number of ambulatory surgical centers is another crucial factor that propels growth of the market.
Based on region, the surgical drains market is analyzed across North America, Europe, Asia-Pacific and LAMEA. North America was the largest shareholder in the surgical drains market in 2020. Owing to the increase in geriatric population, R&D investments and supportive government initiatives directed toward the reduction of the chronic diseases are the major factors driving the growth of the surgical drains market. Asia-Pacific is estimated to grow in the forecast period. Due to the increasing number of surgical procedures, the rising emphasis of prominent players in enhancing their presence, prevalence of chronic disorders and high demand for advanced care products in the region.
Key findings of the Study
- By product type, the closed surgical drainage system segment was the highest contributor to the market in 2020.
- By type, the active drains were the highest contributor to the market in 2020.
- By end users, the hospital segment is projected to grow at a significant CAGR of 4.0% from 2021 to 2030.
- By region, North America garnered largest revenue share of 4.0%.in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 5.1% during the review period.
Companies Mentioned
- BRAUN MELSUNGEN AG
- BECTON DICKINSON & COMPANY (C.R.BARD, INC.)
- CARDINAL HEALTH INC.
- CONVATEC GROUP PLC
- JOHNSON & JOHNSON (ETHICON INC.)
- MEDLINE INDUSTRIES INC.
- MEDTRONIC PLC.
- REDAX S.P.A
- ROMSONS GROUP PRIVATE. LTD
- STRYKER CORPORATION
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 313 |
| Published | May 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 2054 million |
| Forecasted Market Value ( USD | $ 3075.2 million |
| Compound Annual Growth Rate | 4.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
